Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
11.55
-0.63 (-5.17%)
Oct 28, 2026, 4:00 PM EDT - Market closed
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $336.4 million as of October 28, 2026. It is the 17,286th most valuable company in the world and the 3,076th biggest in the United States. Its market cap has increased by 49.84% in one year.
Market Cap
336.40M
Enterprise Value
306.95M
1-Year Change
49.84%
Global Rank
Country Rank
#3,076 United States
Category
ChartMarket Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $336.40M, an increase of 16.28%. That is a compound annual growth rate of 1.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 336.40M | -26.10% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 357.34M |
| Galectin Therapeutics | 357.01M |
| Contineum Therapeutics | 344.23M |
| Arcturus Therapeutics Holdings | 343.07M |
| Atea Pharmaceuticals | 342.47M |
| Alector | 333.58M |
| X4 Pharmaceuticals | 332.14M |
| Scribe Therapeutics | 332.06M |